Breast cancer as a mitochondrial disorder (review)

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 845-851

  Plak, Katarzyna ^a   Czarnecka, Anna M ^a,b   Krawczyk, Tomasz ^c   Golik, Pawel ^a,d   Bartnik, Ewa ^a,d  

^a UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c CZMP   (Poland)

^d INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Breast cancer; Mitochondria; mtDNA; Mutation; Protein structure

Indexed keywords

MESSENGER RNA; MITOCHONDRIAL DNA; TUMOR MARKER; REACTIVE OXYGEN METABOLITE;

AMINO ACID SUBSTITUTION; BREAST CANCER; CANCER CELL; CANCER RISK; CANCER STAGING; CELL FUNCTION; CELL PROLIFERATION; DISEASE MARKER; DNA POLYMORPHISM; DNA SEQUENCE; GENE FUNCTION; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; GENOMIC INSTABILITY; HUMAN; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SOMATIC MUTATION; TREATMENT PLANNING; AMINO ACID SEQUENCE; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; REACTIVE OXYGEN SPECIES;

EID: 67449093464     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000293     Document Type: Review

References (53)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
3. Levi F, Lucchini F, Negri E and La Vecchia C: Continuing declines in cancer mortality in the European Union. Ann Oncol 18: 593-595, 2007.
4. Welcsh PL and King MC: BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10: 705-713, 2001.
5. Foulkes WD and Narod SA: Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing. Clin Invest Med 18: 473-483, 1995.
6. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L and Freedman AN: Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 42: 749-755, 2005.
7. Walsh T, Casadei S, Coats KH, et al: Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295: 1379-1388, 2006.
8. Debniak T, Scott RJ, Huzarski T, et al: XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat 98: 209-215, 2006.
9. Simpson S: PALB2-new breast-cancer susceptibility gene. Lancet Oncol 8: 105, 2007.
10. Zhu W, Qin W, Bradley P, Wessel A, Puckett CL and Sauter ER: Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 26: 145-152, 2005.
11. Tseng LM, Yin PH, Chi CW, et al: Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 45: 629-638, 2006.
12. Wong LJ: Pathogenic mitochondrial DNA mutations in proteincoding genes. Muscle Nerve 36: 279-293, 2007.
13. Zeviani M and Carelli V: Mitochondrial disorders. Curr Opin Neurol 20: 564-571, 2007.
14. Bartnik E, Lorenc A and Mroczek K: Human mitochondria in health, disease, ageing and cancer. J Appl Genet 42: 65-71, 2001.
15. DiMauro S and Schon EA: The mitochondrial respiratory chain and its disorders. In: Mitochondrial Medicine. DiMauro S, Hirano M and Schon EA (eds). Informa Healthcare, Abingdon, pp7-26, 2006.
16. DiMauro S: Mitochondrial DNA medicine. Biosci Rep 27: 5-9, 2007.
17. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
18. Czarnecka AM, Marino Gammazza A, Di Felice V, Zummo G and Cappello F: Cancer as a 'Mitochondriopathy'. J Cancer Mol 3: 71-79, 2007.
19. Wiesbauer M, Meierhofer D, Mayr JA, Sperl W, Paulweber B and Kofler B: Multiplex primer extension analysis for rapid detection of major European mitochondrial haplogroups. Electrophoresis 27: 3864-3868, 2006.
20. Wallace DC: A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359-407, 2005.
21. Gottlieb E and Tomlinson IP: Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5: 857-866, 2005.
22. Booker LM, Habermacher GM, Jessie BC, et al: North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 175: 463-472, 2006.
23. Petros JA, Baumann AK, Ruiz-Pesini E, et al: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102: 719-724, 2005.
24. Darvishi K, Sharma S, Bhat AK, Rai E and Bamezai RN: Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249: 249-255, 2007.
25. Canter JA, Kallianpur AR, Parl FF and Millikan RC: Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65: 8028-8033, 2005.
26. Bai RK, Leal SM, Covarrubias D, Liu A and Wong LJ: Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67: 4687-4694, 2007.
27. DeHaan C, Habibi-Nazhad B, Yan E, Salloum N, Parliament M and Allalunis-Turner J: Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells. Mol Cancer 3: 19, 2004.
28. Crisma M, Formaggio F, Moretto A and Toniolo C: Peptide helices based on alpha-amino acids. Biopolymers 84: 3-12, 2006.
29. Parrella P, Xiao Y, Fliss M, et al: Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61: 7623-7626, 2001.
30. Tan DJ, Bai RK and Wong LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62: 972-976, 2002.
31. Brandon MC, Lott MT, Nguyen KC, et al: MITOMAP: a human mitochondrial genome database-2004 update. Nucleic Acids Res 33: D611-D613, 2005.
32. Ruiz-Pesini E, Lott MT, Procaccio V, et al: An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35: D823-D828, 2007.
33. Betts M and Russel R: Aminoacid properties and consequences for substitutions. In: Bioinformatic for Geneticist. Barnes M and Gray I (eds). Wiley, 2003.
34. Yoshikawa S: Reaction mechanism and phospholipid structures of bovine heart cytochrome c oxidase. Biochem Soc Trans 33: 934-937, 2005.
35. Ingman M and Gyllensten U: mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res 34: D749-D751, 2006.
36. Brandon M, Baldi P and Wallace DC: Mitochondrial mutations in cancer. Oncogene 25: 4647-4662, 2006.
37. Gonzalo R, Garcia-Arumi E, Llige D, et al: Free radicals-mediated damage in transmitochondrial cells harboring the T14487C mutation in the ND6 gene of mtDNA. FEBS Lett 579: 6909-6913, 2005.
38. Baracca A, Sgarbi G, Mattiazzi M, et al: Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. Biochim Biophys Acta 1767: 913-919, 2007.
39. Vives-Bauza C, Gonzalo R, Manfredi G, Garcia-Arumi E and Andreu AL: Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett 391: 136-141, 2006.
40. Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V and Wallace DC: Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303: 223-226, 2004.
41. Salas A, Yao YG, Macaulay V, Vega A, Carracedo A and Bandelt HJ: A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2: E296, 2005.
42. Bandelt HJ, Achilli A, Kong QP, et al: Low 'penetrance' of phylogenetic knowledge in mitochondrial disease studies. Biochem Biophys Res Commun 333: 122-130, 2005.
43. Salas A, Carracedo A, Macaulay V, Richards M and Bandelt HJ: A practical guide to mitochondrial DNA error prevention in clinical, forensic, and population genetics. Biochem Biophys Res Commun 335: 891-899, 2005.
44. Ishikawa K, Takenaga K, Akimoto M, et al: ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320: 661-664, 2008.
45. Poirot O, O'Toole E and Notredame C: Tcoffeeιgs: A web server for computing, evaluating and combining multiple sequence alignments. Nucleic Acids Res 31: 3503-3506, 2003.
46. Berman HM, Westbrook J, Feng Z, et al: The protein data bank. Nucleic Acids Res 28: 235-242, 2000.
47. Tsukihara T, Aoyama H, Yamashita E, et al: The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 272: 1136-1144, 1996.
48. Pettersen EF, Goddard TD, Huang CC, et al: UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612, 2004.
49. Wang CY, Wang HW, Yao YG, Kong QP and Zhang YP: Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer 121: 1253-1256, 2007.
50. Zhu W, Qin W and Sauter ER: Large-scale mitochondrial DNA deletion mutations and nuclear genome instability in human breast cancer. Cancer Detect Prev 28: 119-126, 2004.
51. Wang Y, Liu VW, Tsang PC, et al: Microsatellite instability in mitochondrial genome of common female cancers. Int J Gynecol Cancer 16 (Suppl 1): 259-266, 2006.
52. Isaacs C, Cavalli LR, Cohen Y, et al: Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from high-risk patients. Breast Cancer Res Treat 84: 99-105, 2004.
53. Gallardo ME, Moreno-Loshuertos R, Lopez C, et al: m.6267G>A: a recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors. Hum Mutat 27: 575-582, 2006.